An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function. A prostate cancer journey can involve plenty of questions.

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

Using MRI instead of CT guidance to zero in on prostate tumors enables more precise delivery of SBRT and lowers side effect rates. MRI vs CT guidance reduces side effects from prostate cancer ...

A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...

For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

Radiotherapy, a standard of care treatment for localized prostate cancer includes, has shown remarkable success. This procedure, involving the application of external high-energy radiation to kill ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...

Researchers in the Prostate Cancer Outcomes Study are tracking long-term side effects among patients who underwent radical prostatectomy or radiation therapy for localized prostate cancer. Two-year ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...